1. Murphy CC, Cirillo PM, Krigbaum NY, Cohn BA. In utero exposureto 17α-hydroxyprogesterone caproate and risk of cancer in offspring.Am J Obstet Gynecol. 2022;226(1):132.e1-132.e14. doi:10.1016/j.ajog.2021.10.035
2. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent pretermdelivery by 17 alpha-hydroxyprogesterone caproate [publishedcorrection appears in N Engl J Med. 2003 Sep 25;349(13):1299]. N Engl JMed. 2003;348(24):2379-2385. doi:10.1056/NEJMoa035140
3. Calda P. Safety signals of 17-OHP-C use in pregnancy and efficacyin the prevention of preterm birth. J Matern Fetal Neonatal Med.2009;22(6):540-542. doi:10.1080/14767050802556042
4. Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl JMed. 2007;357(5):454-461. doi:10.1056/NEJMoa070641
5. Combs CA, Garite T, Maurel K, Das A, Porto M; ObstetrixCollaborative Research Network. 17-hydroxyprogesterone caproate fortwin pregnancy: a double-blind, randomized clinical trial. Am J ObstetGynecol. 2011;204(3):221.e1-221.e2218. doi:10.1016/j.ajog.2010.12.042
6. Hendrickx AG, Korte R, Leuschner F, et al. Embryotoxicity of sexsteroidal hormones in nonhuman primates: II. Hydroxyprogesteronecaproate, estradiol valerate. Teratology. 1987;35(1):129-136. doi:10.1002/tera.1420350116
7. Waters TP, Schultz BAH, Mercer BM, Catalano PM. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.Obstet Gynecol. 2009;114(1):45-49. doi:10.1097/AOG.0b013e3181a9454b
8. Gyamfi C, Horton AL, Momirova V, et al. The effect of 17-alphahydroxyprogesterone caproate on the risk of gestational diabetes insingleton or twin pregnancies. Am J Obstet Gynecol. 2009;201(4):392.e1-392.e3925. doi:10.1016/j.ajog.2009.06.036
9. Blackwell SC, Gyamfi-Bannerman C, Biggio JR Jr, et al. 17-OHPC toPrevent Recurrent Preterm Birth in Singleton Gestations (PROLONGStudy): A Multicenter, International, Randomized Double-Blind Trial.Am J Perinatol. 2020;37(2):127-136. doi:10.1055/s-0039-3400227
10. Boelig RC, Locci M, Saccone G, Gragnano E, Berghella V.Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent pretermbirth in singleton gestations: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022;4(5):100658. doi:10.1016/j.ajogmf.2022.100658